LP
Leerink Partners Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
51
CVS Health
CVS
$93.6B
|
MC
Michael Cherny
| $73.78 | $75 |
2%
upside
| Outperform | 6 months ago |
|
52
Axsome Therapeutics
AXSM
$6.25B
|
MG
Marc Goodman
| $125.17 | $150 |
20%
upside
| Outperform | 6 months ago |
|
53
Doximity
DOCS
$13B
|
MC
Michael Cherny
| $69.34 | $90 |
30%
upside
| Outperform | 7 months ago |
|
54
Hologic
HOLX
$14.8B
|
PS
Puneet Souda
| $66.76 | $75 |
12%
upside
| Market Perform | 7 months ago |
|
55
Regeneron Pharmaceuticals
REGN
$60.8B
|
DR
David Risinger
| $573.38 | $834 |
45%
upside
| Outperform | 7 months ago |
|
|
56
Regeneron Pharmaceuticals
REGN
$60.8B
|
AB
Andrew Berens
| $573.38 | $762 |
33%
upside
| Market Perform | 7 months ago |
|
57
Vir Biotechnology
VIR
$732M
|
RR
Roanna Ruiz
| $5.27 | $20 |
280%
upside
| Outperform | 7 months ago |
|
58
ARS Pharmaceuticals
SPRY
$995M
|
RR
Roanna Ruiz
| $10.07 | $27 |
168%
upside
| Outperform | 7 months ago |
|
59
4D Molecular Therapeutics
FDMT
$340M
|
MF
Mani Foroohar
| $7.27 | $27 |
271%
upside
| Outperform | 7 months ago |
|
60
Merck
MRK
$212B
|
DG
Daina Graybosch
| $84.71 | $119 |
40%
upside
| Outperform | 7 months ago |
|
61
Align Technology
ALGN
$10.1B
|
MC
Michael Cherny
| $139.12 | $280 |
101%
upside
| Outperform | 8 months ago |
|
62
Quest Diagnostics
DGX
$20.5B
|
MC
Michael Cherny
| $183.49 | $174 |
5%
downside
| Outperform | 8 months ago |
|
63
Kymera Therapeutics
KYMR
$3.11B
|
FK
Faisal Khurshid
| $43.51 | $60 |
38%
upside
| Outperform | 8 months ago |
|
64
uniQure
QURE
$985M
| $17.95 | $44 |
145%
upside
| Outperform | 9 months ago |
|
|
65
ANI Pharmaceuticals
ANIP
$2.07B
|
FK
Faisal Khurshid
| $95.35 | $80 |
16%
downside
| Outperform | 9 months ago |
|
66
Myriad Genetics
MYGN
$615M
|
PS
Puneet Souda
| $6.61 | $21 |
218%
upside
| Market Perform | 9 months ago |
|
67
Relay Therapeutics
RLAY
$710M
|
CL
Christopher Liu
| $4.12 | $18 |
337%
upside
| Outperform | 9 months ago |
|
68
Janux Therapeutics
JANX
$1.44B
|
JLR
Jeffrey La Rosa
| $23.98 | $91 |
279%
upside
| Outperform | 9 months ago |
|
69
AbbVie
ABBV
$375B
|
DR
David Risinger
| $212.56 | $206 |
3%
downside
| Outperform | 9 months ago |
|
70
IQVIA
IQV
$31.9B
|
MC
Michael Cherny
| $187.68 | $248 |
32%
upside
| Outperform | 9 months ago |
|
71
Icon
ICLR
$13.6B
|
MC
Michael Cherny
| $174.88 | $255 |
46%
upside
| Outperform | 9 months ago |
|
72
Enhabit
EHAB
$395M
|
WM
Whit Mayo
| $7.79 | $8 |
3%
upside
| Market Perform | 9 months ago |
|
73
Neurogene
NGNE
$285M
|
MF
Mani Foroohar
| $19.95 | $72 |
261%
upside
| Outperform | 9 months ago |
|
|
ARDT
74
Ardent Health, Inc.
ARDT
$1.88B
|
WM
Whit Mayo
| $13.16 | $25 |
90%
upside
| Outperform | 9 months ago |
|
75
Bristol-Myers Squibb
BMY
$96B
|
DR
David Risinger
| $47.14 | $73 |
55%
upside
| Outperform | 9 months ago |
|